8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001193125-17-348213
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d495338d8k.htm…